Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
Predicted Reactivity
Pr
Purification
This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This ITM2B antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 218-247 amino acids from the C-terminal region of human ITM2B.
ABRI antibody, BRI antibody, BRI2 antibody, BRICD2B antibody, E25B antibody, E3-16 antibody, FBD antibody, imBRI2 antibody, AI256040 antibody, Bri antibody, Bri2 antibody, Bricd2b antibody, D14Sel6 antibody, E25BMM antibody, itm2b antibody, zgc:55770 antibody, zgc:85688 antibody, wu:fc05f02 antibody, MGC52745 antibody, MGC76131 antibody, ITM2B antibody, itm2bl antibody, wu:fb94b03 antibody, zgc:64142 antibody, integral membrane protein 2B antibody, integral membrane protein 2Ba antibody, integral membrane protein 2B L homeolog antibody, integral membrane protein 2b antibody, integral membrane protein 2Bb antibody, ITM2B antibody, Itm2b antibody, itm2ba antibody, itm2b.L antibody, itm2b antibody, itm2bb antibody
Background
Amyloid precursor proteins are processed by beta-secretase and gamma-secretase to produce beta-amyloid peptides which form the characteristic plaques of Alzheimer disease. This gene encodes a transmembrane protein which is processed at the C-terminus by furin or furin-like proteases to produce a small secreted peptide which inhibits the deposition of beta-amyloid. Mutations which result in extension of the C-terminal end of the encoded protein, thereby increasing the size of the secreted peptide, are associated with two neurogenerative diseases, familial British dementia and familial Danish dementia.